Skip to content

A Clinical Comparison of 2 Multifocal Toric XR (Extended Range) Contact Lenses

A Clinical Comparison of the Comfilcon A (Extended Range) XR Toric Multifocal and Omafilcon B Toric XR Multifocal Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03006458
Enrollment
24
Registered
2016-12-30
Start date
2016-12-31
Completion date
2017-04-06
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

This study aims to compare the clinical performance and subjective acceptance of the comfilcon A and the omafilcon B soft contact lenses.

Detailed description

This will be a randomized, subject-masked, crossover, bilateral study, controlled by cross comparison. Thirty subjects will use each lens type for two weeks in random sequence. Follow-up visits for each lens will be performed after two weeks of wear. Lenses will be worn on a daily wear basis. The final optical design of comfilcon A contact lens was optimized to improve the quality and two further studies (CV-18-10 and CV-18-11) were conducted after completion of this study to evaluate the modified optical design.

Interventions

DEVICEcomfilcon A

toric contact lens

DEVICEomafilcon B

toric contact lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects will only be eligible for the study if: 1. They are aged 40 - 70 years, inclusive. 2. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent. 3. They are willing and able to follow the protocol. 4. They have successfully completed the non-dispensing study (C16-597) as the lenses to be worn on this study (C16-599) are predetermined from their participation on study C16-597. 5. They have a contact lens spherical prescription between +10.00 to -10.00D (Diopters) (inclusive). 6. They have astigmatism between of -0.75 and -5.75DC (based on the calculated ocular refraction) in each eye. 7. They have an Add component to their spectacle refraction (between +0.75 and +2.50DS). 8. They can be satisfactorily fitted with the study lenses. 9. They can attain at least 0.30 logMAR binocular distance high contrast visual acuity with the study lenses within the available power range. 10. They have successfully worn soft contact lenses in the last two years. 11. They are willing to comply with the wear schedule (at least five days per week and for at least six hours per day). 12. They agree not to participate in other clinical research for the duration of this study. 13. They own a wearable pair of spectacles.

Exclusion criteria

* Subjects will not be eligible to take part in the study if: 1. They have an ocular disorder which would normally contra-indicate contact lens wear. 2. They have a systemic disorder which would normally contra-indicate contact lens wear. 3. They are using any topical medication such as eye drops or ointment. 4. They have had cataract surgery. 5. They have had corneal refractive surgery. 6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. 7. They are pregnant or breast-feeding. 8. They have any clinically meaningful slit lamp findings contraindicating contact lens wear (e.g. ≥ Grade 3 finding of oedema, corneal neovascularisation, corneal staining, tarsal abnormalities, conjunctival injection, blepharitis/meibomian gland dysfunction) on the Efron classification scale or any other ocular abnormality that in the opinion of the investigator would contraindicate contact lens wear. 9. They have any infectious disease (e.g. hepatitis) which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV). 10. They have a history of anaphylaxis or severe allergic reaction. 11. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Design outcomes

Primary

MeasureTime frameDescription
StabilityBaselineInvestigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.
Overall Toric Lens Fit AcceptanceBaselineOverall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.
ComfortBaselineSubjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever
Overall Satisfaction2 weeksSubjective ratings for overall satisfaction for comfilcon A and omafilcon B lenses assessed. Scale 0-100, 0=extremely dissatisfied, 100=extremely satisfied
Dryness2 weeksSubjective ratings for dryness assessed. Scale 0-100, 0=cannot be worn, extremely dry; 100=no dryness experienced at any time
Visual Fluctuation/ Stability2 weeksSubjective ratings for visual fluctuation/stability assessed. Scale 0-100, 0=totally unstable/ fluctuation/changing; 100=perfectly stable/not fluctuation/changing
Handling2 weeksSubjective ratings for handling difficulty assessed at 2 weeks. Scale 0-100, 0=very difficult, 100=very easy
Quality of Near Vision2 weeksSubjective ratings for quality of near vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.
Quality of Intermediate Vision2 weeksSubjective ratings for quality of intermediate vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.
Quality of Distance Vision2 weeksSubjective ratings for quality of distance vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.
Quality of Vision While Driving During the Day2 weeksSubjective rating for quality of vision while driving during the day. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.
Quality of Vision While Driving During the Night2 weeksSubjective ratings for quality of vision while driving at night. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.
Ghosting at Near2 weeksSubjective ratings for ghosting at near assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.
Ghosting at Distance2 weeksSubjective ratings for ghosting at distance assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Overall Study
Total Participants
24
Total24

Withdrawals & dropouts

PeriodReasonFG000FG001
First InterventionUnsatisfied Vision03

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
24 Participants
Age, Continuous56.2 years
STANDARD_DEVIATION 6.2
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United Kingdom
24 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 21
other
Total, other adverse events
0 / 240 / 21
serious
Total, serious adverse events
0 / 240 / 21

Outcome results

Primary

Comfort

Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Comfilcon AComfort81.6 units on a scaleStandard Deviation 20.3
Omafilcon BComfort79.7 units on a scaleStandard Deviation 21.6
Primary

Comfort

Subjective ratings for comfort assessed. Scale 0-100, 0=cannot be worn, causes pain; 100=cannot be felt ever

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AComfort79.8 units on a scaleStandard Deviation 21.8
Omafilcon BComfort70.6 units on a scaleStandard Deviation 27.2
Primary

Dryness

Subjective ratings for dryness assessed. Scale 0-100, 0=cannot be worn, extremely dry; 100=no dryness experienced at any time

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon ADryness80.4 units on a scaleStandard Deviation 24.7
Omafilcon BDryness77.2 units on a scaleStandard Deviation 24.1
Primary

Ghosting at Distance

Subjective ratings for ghosting at distance assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AGhosting at Distance83.3 units on a scaleStandard Deviation 24.8
Omafilcon BGhosting at Distance86.9 units on a scaleStandard Deviation 24.4
Primary

Ghosting at Near

Subjective ratings for ghosting at near assessed at 2 weeks. Scale 0-100, 0=intolerable, 100=not noticeable.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AGhosting at Near66.5 units on a scaleStandard Deviation 35
Omafilcon BGhosting at Near78.1 units on a scaleStandard Deviation 27
Primary

Handling

Subjective ratings for handling difficulty assessed at 2 weeks. Scale 0-100, 0=very difficult, 100=very easy

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AHandling84.5 units on a scaleStandard Deviation 15
Omafilcon BHandling85.8 units on a scaleStandard Deviation 17.1
Primary

Overall Satisfaction

Subjective ratings for overall satisfaction for comfilcon A and omafilcon B lenses assessed. Scale 0-100, 0=extremely dissatisfied, 100=extremely satisfied

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AOverall Satisfaction63.0 units on a scaleStandard Deviation 31.4
Omafilcon BOverall Satisfaction63.3 units on a scaleStandard Deviation 34.4
Primary

Overall Toric Lens Fit Acceptance

Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AOverall Toric Lens Fit Acceptance3.5 units on a scaleStandard Deviation 0.6
Omafilcon BOverall Toric Lens Fit Acceptance2.8 units on a scaleStandard Deviation 0.7
Primary

Overall Toric Lens Fit Acceptance

Overall toric lens fit acceptance is assessed for comfilcon A and omafilcon B lenses. Scale 0-4, 0=can't be worn, 1=Poor, 2=Fair, 3=Good, 4=optimum.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Comfilcon AOverall Toric Lens Fit Acceptance3.3 units on a scaleStandard Deviation 0.5
Omafilcon BOverall Toric Lens Fit Acceptance3.2 units on a scaleStandard Deviation 0.6
Primary

Quality of Distance Vision

Subjective ratings for quality of distance vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AQuality of Distance Vision86.2 units on a scaleStandard Deviation 13.7
Omafilcon BQuality of Distance Vision67.3 units on a scaleStandard Deviation 25.5
Primary

Quality of Intermediate Vision

Subjective ratings for quality of intermediate vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AQuality of Intermediate Vision50.2 units on a scaleStandard Deviation 29.5
Omafilcon BQuality of Intermediate Vision65.3 units on a scaleStandard Deviation 25.6
Primary

Quality of Near Vision

Subjective ratings for quality of near vision. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AQuality of Near Vision38.5 units on a scaleStandard Deviation 30.5
Omafilcon BQuality of Near Vision56.4 units on a scaleStandard Deviation 28.9
Primary

Quality of Vision While Driving During the Day

Subjective rating for quality of vision while driving during the day. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AQuality of Vision While Driving During the Day87.3 units on a scaleStandard Deviation 14.6
Omafilcon BQuality of Vision While Driving During the Day76.2 units on a scaleStandard Deviation 25.4
Primary

Quality of Vision While Driving During the Night

Subjective ratings for quality of vision while driving at night. Scale 0-100, 0=extremely poor vision all of the time. cannot function, 100 - excellent vision all of the time.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AQuality of Vision While Driving During the Night78.0 units on a scaleStandard Deviation 18.6
Omafilcon BQuality of Vision While Driving During the Night67.0 units on a scaleStandard Deviation 23.4
Primary

Stability

Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Comfilcon AStability3.2 units on a scaleStandard Deviation 1.5
Omafilcon BStability2.9 units on a scaleStandard Deviation 0.9
Primary

Stability

Investigator's acceptance on overall stability for comfilcon A and omafilcon B lenses assessed using grading scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for astigmatism, 4=Excellent orientation and optimum rotational.

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AStability3.2 units on a scaleStandard Deviation 0.7
Omafilcon BStability2.5 units on a scaleStandard Deviation 1
Primary

Visual Fluctuation/ Stability

Subjective ratings for visual fluctuation/stability assessed. Scale 0-100, 0=totally unstable/ fluctuation/changing; 100=perfectly stable/not fluctuation/changing

Time frame: 2 weeks

ArmMeasureValue (MEAN)Dispersion
Comfilcon AVisual Fluctuation/ Stability81.0 units on a scaleStandard Deviation 16.1
Omafilcon BVisual Fluctuation/ Stability73.8 units on a scaleStandard Deviation 25.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026